Effect of bronchial asthma on the condition of the oral cavity

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND: High-quality dental rehabilitation of patients suffering from bronchial asthma is one of the priority tasks of an integrated approach to the treatment of a general somatic pathology. To date, changes in the oral cavity are polyetiological and can be associated with xerostomia, nutrition, nature of treatment, and poor hygiene. Thus, the microbial factor may play an important role in the development of pathological changes in the oral cavity.

AIM: Through a literature review, this study aimed to examine typical and atypical types of microbial colonies developing in the oral cavity of patients with bronchial asthma and study ways to correct the pathogenic microflora of the oral cavity.

MATERIALS AND METHODS: An analysis was made of information sources in the international databases of Google Scholar, PubMed, and eLIBRARY.RU from 2000 to 2023. The keywords of the query were “oral cavity”, “bronchial asthma”, “microbes”, “antimicrobial therapy”.

RESULTS: The literature search extracted 118 sources, of which 34 were relevant. Patients diagnosed with bronchial asthma were found to have dental problems associated with conditions associated with bacterial flora, such as caries, periodontal diseases, and candidiasis. Inflammatory and autoimmune processes were activated by the action of pathogenic microflora.

CONCLUSION: Changes in the microbial balance have affected the development of oral cavity pathologies. Correct hygiene and use of antibacterial and antifungal agents, intake of low-dose drugs, or avoidance of drugs that stimulate the increase in pathogenic microbes, contribute to a decrease in the microbial pathological potential in the oral cavity.

About the authors

Natalia A. Latysh

Peoples’ Friendship University of Russia named after Patrice Lumumba

Email: dr.latysh1978@mail.ru
ORCID iD: 0009-0001-0631-9819
Russian Federation, Moscow

Svetlana N. Razumova

Peoples’ Friendship University of Russia named after Patrice Lumumba

Email: razumova_sv@mail.ru
ORCID iD: 0000-0002-9533-9204
SPIN-code: 6771-8507

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Moscow

Nikolai V. Sturov

Peoples’ Friendship University of Russia named after Patrice Lumumba

Email: sturov-nv@rudn.ru
ORCID iD: 0000-0002-3138-8410
SPIN-code: 2805-9823

Cand. Sci. (Medicine), Associate Professor

Russian Federation, Moscow

Anzhela S. Brago

Peoples’ Friendship University of Russia named after Patrice Lumumba

Author for correspondence.
Email: anzhela_bogdan@mail.ru
ORCID iD: 0000-0001-8947-4357
SPIN-code: 2437-8867

MD, Cand. Sci. (Medicine), Associate Professor

Russian Federation, Moscow

References

  1. The Global Asthma Report. Int J Tuberc Lung Dis. 2022;26 (Suppl. 1):1–104. doi: 10.5588/ijtld.22.1010
  2. Chang J, Mosenifar Z. Differentiating COPD from asthma in clinical practice. J Intensive Care Med. 2007;22(5):300–309. doi: 10.1177/0885066607304445
  3. Chuchalin AG. Pneumonia: the urgent problem of 21st century medicine. Terapevticheskii arkhiv. 2016;88(3):4–12. EDN: VOONWP doi: 10.17116/terarkh20168834-12
  4. Lötvall J, Akdis CA, Bacharier LB, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127(2):355–360. doi: 10.1016/j.jaci.2010.11.037
  5. Sag C, Ozden FO, Acikgoz G, Anlar FY. The effects of combination treatment with a long-acting beta2-agonist and a corticosteroid on salivary flow rate, secretory immunoglobulin A, and oral health in children and adolescents with moderate asthma: a 1-month, single-blind clinical study. Clin Ther. 2007;29(10):2236–2242. doi: 10.1016/j.clinthera.2007.10.014
  6. Ramsey CD, Gold DR, Litonjua AA, et al. Respiratory illnesses in early life and asthma and atopy in childhood. J Allergy Clin Immunol. 2007;119(1):150–156. doi: 10.1016/j.jaci.2006.09.012
  7. Al-Ramahi N, Al-Najjar MAA, Jabaley A, et al. Variations in the respiratory microbiota amongst asthmatic and non-asthmatic subjects in Jordan. Saudi J Biol Sci. 2022;29(10):103406. doi: 10.1016/j.sjbs.2022.103406
  8. Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med. 2011;184(8):957–963. doi: 10.1164/rccm.201104-0655OC
  9. Innes JA, Reid PT. Respiratory diseases. In: Boon NA, Colledge NR, Walker BR, Hunter JA, editors. Davidson’s principles and practice of medicine. 20th ed. Churchill Livingstone: Elsevier; 2006. P. 670–678.
  10. Peng X, Cheng L, You Y, et al. Oral microbiota in human systematic diseases. Int J Oral Sci. 2022;14(1):14. doi: 10.1038/s41368-022-00163-7
  11. Tuganbaev T, Yoshida K, Honda K. The effects of oral microbiota on health. Science. 2022;376(6596):934–936. doi: 10.1126/science.abn1890
  12. Belibasakis GN, Bostanci N, Marsh PD, Zaura E. Applications of the oral microbiome in personalized dentistry. Arch Oral Biol. 2019;104:7–12. doi: 10.1016/j.archoralbio.2019.05.023
  13. Zhu J, Chu W, Luo J, et al. Dental materials for oral microbiota dysbiosis: an update. Front Cell Infect Microbiol. 2022;12:900918. doi: 10.3389/fcimb.2022.900918
  14. Wade WG, Prosdocimi EM. Profiling of oral bacterial communities. J Dent Res. 2020;99(6):621–629. doi: 10.1177/0022034520914594
  15. Bourdin A, Gras D, Vachier I, Chanez P. Upper airway x 1: allergic rhinitis and asthma: united disease through epithelial cells. Thorax. 2009;64(11):999–1004. doi: 10.1136/thx.2008.112862
  16. Erb-Downward JR, Thompson DL, Han MK, et al. Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS One. 2011;6(2):e16384. doi: 10.1371/journal.pone.0016384
  17. Garzoni C, Brugger SD, Qi W, et al. Microbial communities in the respiratory tract of patients with interstitial lung disease. Thorax. 2013;68(12):1150–1156. doi: 10.1136/thoraxjnl-2012-202917
  18. Noverr MC, Huffnagle GB. The ‘microflora hypothesis’ of allergic diseases. Clin Exp Allergy. 2005;35(12):1511–1520. doi: 10.1111/j.1365-2222.2005.02379.x
  19. Reddel HK, FitzGerald JM, Bateman ED, et al. GINA 2019: a fundamental change in asthma management: treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents. Eur Respir J. 2019;53(6):1901046. doi: 10.1183/13993003.01046-2019
  20. Song X, Greiner-Tollersrud OK, Zhou H. Oral microbiota variation: a risk factor for development and poor prognosis of esophageal cancer. Dig Dis Sci. 2022;67(8):3543–3556. doi: 10.1007/s10620-021-07245-2
  21. Samec T, Jan J. Developmental defects of enamel among Slovenian asthmatic children. Eur J Paediatr Dent. 2022;23(2):121–124. doi: 10.23804/ejpd.2022.23.02.14
  22. Ersin NK, Gülen F, Eronat N, et al. Oral and dental manifestations of young asthmatics related to medication, severity and duration of condition. Pediatr Int. 2006;48(6):549–554. doi: 10.1111/j.1442-200X.2006.02281.x
  23. Reddy DK, Hegde AM, Munshi AK. Dental caries status of children with bronchial asthma. J Clin Pediatr Dent. 2003;27(3):293–295.
  24. Chuang CY, Sun HL, Ku MS. Allergic rhinitis, rather than asthma, is a risk factor for dental caries. Clin Otolaryngol. 2018;43(1):131–136. doi: 10.1111/coa.12912
  25. Stensson M, Wendt LK, Koch G, et al. Oral health in preschool children with asthma. Int J Paediatr Dent. 2008;18(4):243–250. doi: 10.1111/j.1365-263X.2008.00921.x
  26. Stensson M, Wendt LK, Koch G, et al. Oral health in young adults with long-term, controlled asthma. Acta Odontol Scand. 2011;69(3):158–164. doi: 10.3109/00016357.2010.547516
  27. Mehtonen IT, Rantala AK, Hugg TT, et al. Dental caries is associated with lower respiratory tract infections: a population-based cohort study. Respir Med. 2019;158:1–5. doi: 10.1016/j.rmed.2019.09.002
  28. Alavaikko S, Jaakkola MS, Tjäderhane L, Jaakkola JJ. Asthma and caries: a systematic review and meta-analysis. Am J Epidemiol. 2011;174(6):631–641. doi: 10.1093/aje/kwr129
  29. Shashikiran ND, Reddy VV, Raju PK. Effect of antiasthmatic medication on dental disease: dental caries and periodontal disease. J Indian Soc Pedod Prev Dent. 2007;25(2):65–68. doi: 10.4103/0970-4388.33450
  30. Ryberg M, Möller C, Ericson T. Effect of beta 2-adrenoceptor agonists on saliva proteins and dental caries in asthmatic children. J Dent Res. 1987;66(8):1404–1406. doi: 10.1177/00220345870660082401
  31. Gani F, Caminati M, Bellavia F, et al. Oral health in asthmatic patients: a review: asthma and its therapy may impact on oral health. Clin Mol Allergy. 2020;18(1):22. doi: 10.1186/s12948-020-00137-2
  32. de Almeida Pdel V, Grégio AM, Machado MA, et al. Saliva composition and functions: a comprehensive review. J Contemp Dent Pract. 2008;9(3):72–80. doi: 10.5005/jcdp-9-3-72
  33. Johansson I, Ericson T. Saliva composition and caries development during protein deficiency and beta-receptor stimulation or inhibition. J Oral Pathol. 1987;16(3):145–149. doi: 10.1111/j.1600-0714.1987.tb01482.x
  34. Kargul B, Tanboga I, Ergeneli S, et al. Inhaler medicament effects on saliva and plaque pH in asthmatic children. J Clin Pediatr Dent. 1998;22(2):137–140.
  35. Ryberg M, Möller C, Ericson T. Saliva composition and caries development in asthmatic patients treated with beta 2-adrenoceptor agonists: a 4-year follow-up study. Scand J Dent Res. 1991;99(3):212–218. doi: 10.1111/j.1600-0722.1991.tb01887.x
  36. Yalçın SS, Emiralioğlu N, Yalçın S. Evaluation of blood and tooth element status in asthma cases: a preliminary case-control study. BMC Pulm Med. 2021;21(1):201. doi: 10.1186/s12890-021-01565-9
  37. Fathima R, Shenoy R, Jodalli PS, et al. Evaluation of salivary parameters and oral health status among asthmatic and nonasthmatic adult patients visiting a tertiary care hospital. Cureus. 2019;11(10):e5957. doi: 10.7759/cureus.5957
  38. Mehta A, Sequeira PS, Sahoo RC, Kaur G. Is bronchial asthma a risk factor for gingival diseases? A control study. N Y State Dent J. 2009;75(1):44–46.
  39. Ferreira MKM, Ferreira RO, Castro MML, et al. Is there an association between asthma and periodontal disease among adults? Systematic review and meta-analysis. Life Sci. 2019;223:74–87. doi: 10.1016/j.lfs.2019.03.005
  40. Irwin RS, Richardson ND. Side effects with inhaled corticosteroids: the physician’s perception. Chest. 2006;130(Suppl. 1):41S–53S. doi: 10.1378/chest.130.1_suppl.41S
  41. Mortimer KJ, Harrison TW, Tattersfield AE. Effects of inhaled corticosteroids on bone. Ann Allergy Asthma Immunol. 2005;94(1):15–79. doi: 10.1016/S1081-1206(10)61280-X
  42. Heffler E, Madeira LNG, Ferrando M, et al. Inhaled corticosteroids safety and adverse effects in patients with asthma. J Allergy Clin Immunol Pract. 2018;6(3):776–781. doi: 10.1016/j.jaip.2018.01.025
  43. Shen TC, Chang PY, Lin CL, et al. Risk of periodontal disease in patients with asthma: a nationwide population-based retrospective cohort study. J Periodontol. 2017;88(8):723–730. doi: 10.1902/jop.2017.160414
  44. Fukushima C, Matsuse H, Saeki S, et al. Salivary IgA and oral candidiasis in asthmatic patients treated with inhaled corticosteroid. J Asthma. 2005;42(7):601–604. doi: 10.1080/02770900500216259
  45. Fukushima C, Matsuse H, Tomari S, et al. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol. 2003;90(6):646–651. doi: 10.1016/S1081-1206(10)61870-4
  46. Pandya D, Puttanna A, Balagopal V. Systemic effects of inhaled corticosteroids: an overview. Open Respir Med J. 2014;8:59–65. doi: 10.2174/1874306401408010059
  47. Hanania NA, Chapman KR, Sturtridge WC, et al. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol. 1995;96(5 Pt 1):571–579. doi: 10.1016/s0091-6749(95)70254-7
  48. Wactawski-Wende J. Periodontal diseases and osteoporosis: association and mechanisms. Ann Periodontol. 2001;6(1):197–208. doi: 10.1902/annals.2001.6.1.197
  49. Han ER, Choi IS, Kim HK, et al. Inhaled corticosteroid-related tooth problems in asthmatics. J Asthma. 2009;46(2):160–164. doi: 10.1080/02770900802553102
  50. Choi H, Bae KH, Lee JW. Association between age at asthma diagnosis and tooth loss. Acta Odontol Scand. 2018;76(7):466–472. doi: 10.1080/00016357.2018.1436723
  51. Roland NJ, Bhalla RK, Earis J. The local side effects of inhaled corticosteroids: current understanding and review of the literature. Chest. 2004;126(1):213–219. doi: 10.1378/chest.126.1.213
  52. Kurt E, Yildirim H, Kiraz N, et al. Oropharyngeal candidiasis with dry-powdered fluticasone propionate: 500 microg/day versus 200 microg/day. Allergol Immunopathol (Madr). 2008;36(1):17–20. doi: 10.1157/13115666
  53. Ellepola AN, Samaranayake LP. Inhalational and topical steroids, and oral candidosis: a mini review. Oral Dis. 2001;7(4):211–216. doi: 10.1034/j.1601-0825.2001.70402.x
  54. Tootla R, Toumba KJ, Duggal MS. An evaluation of the acidogenic potential of asthma inhalers. Arch Oral Biol. 2004;49(4):275–283. doi: 10.1016/j.archoralbio.2003.11.006
  55. Torres SR, Peixoto CB, Caldas DM, et al. Relationship between salivary flow rates and Candida counts in subjects with xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(2):149–154. doi: 10.1067/moe.2002.119738
  56. Samaranayake LP, Hughes A, Weetman DA, MacFarlane TW. Growth and acid production of Candida species in human saliva supplemented with glucose. J Oral Pathol. 1986;15(5):251–254. doi: 10.1111/j.1600-0714.1986.tb00617.x
  57. Selroos O, Löfroos AB, Pietinalho A, Riska H. Asthma control and steroid doses 5 years after early or delayed introduction of inhaled corticosteroids in asthma: a real-life study. Respir Med. 2004;98(3):254–262. doi: 10.1016/j.rmed.2003.10.007
  58. Salzman GA, Pyszczynski DR. Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber. J Allergy Clin Immunol. 1988;81(2):424–428. doi: 10.1016/0091-6749(88)90911-6
  59. Lyu X, Zhao C, Yan ZM, Hua H. Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis. Drug Des Devel Ther. 2016;10:1161–1171. doi: 10.2147/DDDT.S100795
  60. McDerra EJ, Pollard MA, Curzon ME. The dental status of asthmatic British school children. Pediatr Dent. 1998;20(4):281–287.
  61. Kenny DJ, Somaya P. Sugar load of oral liquid medications on chronically ill children. J Can Dent Assoc. 1989;55(1):43–46.
  62. Bjerkeborn K, Dahllöf G, Hedlin G, et al. Effect of disease severity and pharmacotherapy of asthma on oral health in asthmatic children. Scand J Dent Res. 1987;95(2):159–164. doi: 10.1111/j.1600-0722.1987.tb01824.x
  63. Eloot AK, Vanobbergen JN, De Baets F, Martens LC. Oral health and habits in children with asthma related to severity and duration of condition. Eur J Paediatr Dent. 2004;5(4):210–215.
  64. Hyyppä TM, Koivikko A, Paunio KU. Studies on periodontal conditions in asthmatic children. Acta Odontol Scand. 1979;37(1):15–20. doi: 10.3109/00016357909004680
  65. Knight L, Fletcher J. Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids, and diabetes mellitus. J Infect Dis. 1971;123(4):371–377. doi: 10.1093/infdis/123.4.371

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Eco-Vector


 


Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».